The Hospital opened Praram 9 Medical Center Building B
The Hospital received Certification of Conformance with GHA COVID-19 Guidelines for Medical Travel Services
The Hospital was ranked 10th in the Thailand’s Most Admired Company 2020 in Hospital Category by Brand Age magazine
The Hospital received a trophy in recognition as an outstanding organization which correctly, completely and timely remitted company contribution and transmitted the contribution through electronic channel in support of Thailand 4.0 policy
Year 2019
Accredited JCI 6th Edition and received Accredit Effective Status by JCI
Accredited Clinical Care Program Certification (CCPC) for Kidney Transplant by JCI
Praram 9Kidney Disease & TransplantationInstitute performed exceedinglyup to84 casesof kidney transplant per year and performed totaling more than 900 cases of kidney transplant since 1992.
The Hospital received Thailand Top Company Award 2019 presented by University of the Thai Chamber of Commerce, in collaboration with Business+ magazine of ARiP Public Co., Ltd. (“ARiP”).
The Hospital was ranked No. 8 in the Hospital category and No. 4 in the Private Hospital Category by Brand Age magazine in Thailand’s Most Admired Company 2019.
The Hospital received the Good Governance Hospital (GGH) Certificate for being the good governance hospital with the transparent and reasonable price of drug & services from the Department of Internal Trade, Ministry of Commerce.
Year 2018
The Hospital received AXA Provider Award: Best Utilization Award of 2017 presented by AXA Insurance Public Co., Ltd.
The Hospital received Thailand Top Company Award 2018 presented by University of the Thai Chamber of Commerce, in collaboration with Business+ magazine of ARiP Public Co., Ltd. (“ARiP”).
The Board of Directos No. 3/2018 on 12 March 2018 and the 2018 Annual General Meeting of Shareholders resolved to approve the dividend payment in excess of retained earnings to its sharholders, which paid THB 84 per share in total of 6,000,000 shares (before changing the par value) with the total amount of THB 504,000,000.
The Hospital changed the par value from THB 100 per share to THB 1 per share and increased its registered capitals from THB 600,000,000 to THB 800,000,000 for supporting the first issuance of new ordinary shares to the public. According to the resolution of the 2018 Annual General Meeting of Shareholders on 28 March 2018, the Company applied to list its ordinary shares on the Stock Exchange of Thailand.
The Hospital registered its conversion to Public Company Limited and changed its name to Praram 9 Hospital Public Co., Ltd, on 29 March 2018.
The Memorandum of Agreement for the referral of Kidney transplants’ patients from 9 leading private hospitals, including, Rajyindee Hospital (Hat Yai), Rajyindee Hospital network, Paknampo Hospital network was made. This helped increase access to care for patients with kidney disease living in remote areas.
The Hospital changed its Vision, Mission, and Logo for the first time in 26 years for rebranding to reflect the potential and quality of its healthcare services, according to the resolution of the Board of Directors No. 5/108 on 14 August 2018.
The Hospital was ranked No. 8 in the Hospital category and No. 4 in the Private Hospital Category by BrandAge magazine in Thailand’s Most Admired Company 2018. For the first year of its Hospital that was recognized the top 10 Hospitals of the aforementioned survey.
Year 2017
Praram 9 Kidney Transplantation Institute performed exceedingly up to 82 cases of kidney transplant per year since starts of the operation in 1992.
The Hospital was the first private hospital providing 640-slice CT Scanner. (640-slice CT Scanner)
Year 2016
Accredited JCI 5th Edition and accepted Accredit Effective Status by JCI
Accredited Clinical Care Program Certification (CCPC) in 2 specialty by JCI as follows:
CCPC for Kidney Transplant
The Hospital received Excellence in Healthcare Award by Muang Thai Life Assurance Hospital Awards
Year 2014
The Hospital received Gold Award Hospital Quality presented by American International Assurance Co., Ltd. (“AIA”)
Year 2013
The Hospital increased its licensed bed capacity to 166 beds, including 6 Intensive Care Unit (ICU) and Cardiac Care Unit (CCU) beds
Accredited JCI 4th Edition and accepted Accredit Effective Status by JCI
Praram 9 Kidney Transplantation Institute performed 500 cases of kidney transplant
Year 2011
The Hospital received Gold Award Hospital Quality presented by American International Assurance Co., Ltd. (“AIA”)
Year 2010
Accredited JCI 3rd Edition and accepted Accredit Effective Status by JCI
Year 2009
The Hospital received Gold Award Hospital Quality presented by American International Assurance Co., Ltd. (“AIA”)
Year 2007
Accredited HA (Hospital Accreditation) by the Healthcare Accreditation Institute.
Year 2005
The Hospital was the first private hospital providing 64-slice CT Scanner.
Year 2004
Accredited HA (Hospital Accreditation) by the Healthcare Accreditation Institute.
4D Ultrasound technology was available.
Year 2003
Certified to ISO 9001:2000 Quality Management System.
Year 2001
The capital structure was adjusted by increasing its registered capital from THB 400,000,000 to THB 600,000,000 with issuing 2,000,000 new ordinary shares at a par value of THB 100 and offering to its existing shareholders in order to finance its working capital and settle its liability.
Year 2000
Certified to ISO 9002:1994, which is the standardization of healthcare and environmental management system.
Year 1997
Praram 9 Kidney Transplantation Institute performed 100 cases of kidney transplant.
Year 1992
The Hospital initially operated inpatient care under the name of “Praram 9 Hospital” with 160 licensed beds.
Year 1989
Existing founders purchased all equity of Spac Co., Ltd. and increased its registered capital to THB 400,000,000, divided into 4,000,000 ordinary shares at a par value of THB 100 to its existing and new shareholders, and changed its name to Praram 9 Hospital Co., Ltd. for operating private hospital.
The aforementioned capital was used for facilities construction and operating working capitals.
